The dividend growth trade is doing something unusual in 2026: it is crushing the broad market. The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD | SCHD Price Prediction) is up roughly 17% year to date, while the S&P 500 has returned about 8% over the same stretch. That is an outperformance gap of roughly several percentage points in less than five months, and it has refocused attention on a corner of the market that spent much of the last cycle being ignored.
After working through the full dividend growth ETF landscape, three funds keep ending up at the top of the shortlist: SCHD, the Vanguard Dividend Appreciation ETF (NYSEARCA:VIG), and the iShares Core Dividend Growth ETF (NYSEARCA:DGRO). They are not interchangeable. Each runs a different screen, holds a different basket, and serves a different kind of investor. That is the point of owning more than one.
Why Dividend Growth Is Beating the Index Right Now
The leadership in 2026 has rotated away from the megacap growth names that powered 2024 and into companies with real cash flow, durable balance sheets, and conservative payout policies. Dividend growth funds are screening for exactly that profile. They tilt toward healthcare, energy, financials, defense, and staples, sectors that lagged the AI trade and now trade at sensible multiples.
The funds doing the work in this rally are the ones requiring a track record of raising the dividend, because that screen filters out companies that pay out more than they earn, leaving REIT-heavy and stretched-payer products behind. The result is a portfolio that looks boring on paper and has handily beaten the index this year.
SCHD: The Standout for Current Income
SCHD tracks the Dow Jones U.S. Dividend 100 Index, which applies a three-factor screen most other dividend ETFs do not: a 10-year history of consecutive dividend payments, a cash flow to total debt quality check, and a composite ranking on yield and five-year dividend growth. That third leg is what gives SCHD its value tilt and its higher current yield relative to the other two funds on this list.
The portfolio reflects that screen. Top positions include Bristol-Myers Squibb, Merck, ConocoPhillips, Lockheed Martin, and Chevron, each weighted around 4%, with healthcare, energy, defense, and staples names rounding out the top ten. Weightings are tightly clustered, which keeps single-name risk low even with a concentrated 100-stock book.
The fund carries an expense ratio of 0.06%, one of the cheapest in the dividend category, and manages roughly $72 billion in net assets. The most recent quarterly distribution came in at $0.2569 per share in March, paid on the consistent quarterly cadence SCHD has held since inception. Over one year the fund has returned about 25%, essentially matching the S&P 500 with a meaningfully higher cash yield.
The tradeoff with SCHD is sector concentration. Heavy weights in energy, healthcare, and staples mean the fund can lag sharply when the market is paying up for growth and technology. Investors who bought SCHD in 2023 lived that reality. The 2026 rotation is the reverse trade.
VIG: The Quality Compounder
VIG takes a stricter view of what counts as a dividend grower. The fund tracks the S&P U.S. Dividend Growers Index, which requires at least 10 consecutive years of annual dividend increases and explicitly excludes the top 25% highest yielding eligible names. That exclusion is the whole point. It pushes the portfolio toward companies still in compounding mode rather than payers stretching to defend a high distribution.
The practical result is a megacap-tilted book that looks much closer to the S&P 500 than SCHD does, with larger weights to industrials, financials, and quality technology names that have raised payouts for a decade-plus. The current yield is the lowest of the three funds here, but the dividend growth rate has been steady. VIG paid $0.8334 per share in March, up meaningfully from $0.5131 four years earlier for the comparable quarter.
Performance has been respectable rather than spectacular this year, with VIG up about 5% year to date and roughly 18% over the past year. Its quality screen kept it in higher-multiple growers that did not participate in the value rotation as forcefully as SCHD’s holdings did. For an investor planning to hold for 20 years, that quality screen is exactly the point.
The tradeoff: if you want income today, VIG is the wrong tool. The yield is modest by design. You are buying the rising-payment stream, not the starting check.
DGRO: The Middle Ground
DGRO tracks the Morningstar US Dividend Growth Index, which requires at least five consecutive years of dividend growth and adds a payout ratio screen below 75%. That combination lets the fund include some higher-yielders VIG screens out, while still demanding earnings quality VIG does not explicitly require. It lands between SCHD and VIG on almost every dimension that matters.
The expense ratio of 0.08%, set under iShares’ core lineup pricing, keeps DGRO competitive with the cheapest funds in the category. Its inception in June 2014 gives it more than a decade of live track record. Year to date the fund has returned about 6% with a 20% one-year gain, splitting the difference between SCHD’s value-led surge and VIG’s quality-growth profile.
The dividend cadence has been steady, with the December 2025 payment of $0.4470 per share running well ahead of the prior December’s $0.3780, a sign the underlying holdings are pushing distributions higher. The tradeoff with DGRO is that being a middle-ground product, it rarely tops a leaderboard. In a year like 2026 where SCHD’s screen is in favor, DGRO trails. In a year where megacap growers run, it trails VIG.
Which Fund Fits Which Investor
If you need income today, SCHD is the clearest choice on this list. The higher yield, the value tilt, and the three-factor quality screen do exactly what a retiree or near-retiree wants from an equity sleeve: pay cash now, hold up in drawdowns, and avoid the speculative end of the dividend market.
If you are 20 or 30 years from drawing down the portfolio, VIG is the better long-term compounder. The 10-year increase requirement and the high-yield exclusion both push the fund toward businesses that reinvest, grow, and gradually raise the payment. Those are the holdings you want owning your capital for two decades.
DGRO is the fund for the investor who does not want to choose. It captures most of the dividend growth premium with some current income on top, at a cost basis close to the cheapest funds in the category. For a single-ETF dividend allocation inside a balanced portfolio, that profile is hard to beat. The three funds are complementary, and the reason all three keep showing up on serious shortlists is that each one is the right answer to a different question.
Top Gaining Stocks
Top Losing Stocks